EFFICACY OF MYOCARDIAL REVASCULARIZATION IN POTENTIAL RECIPIENTS OF HEART WITH THE CHRONIC ISCHEMIC HEART FAILURE

Aim: to evaluate clinical effi ciency of percutaneous coronary interventions (PCI) at potential recipients of heart with the chronic ischemic heart failure (CHF).

Materials and methods. In this retrospective study results of treatment at 76 patients with CHF NYHA III and 36 patients with CHF NYHA IV by scheduled PCI are presented. Duration of observation was from 6 to 160 months. The age of patients at the time of intervention was 61,7 ± 0,62 years (from 33 to 76). 108 male and 4 female. Defi ned life expectancy and echocardiography parameters of the left ventricle (LV) of heart.  

Results. 20 patients were died, 16 of them from cardiovascular events. 18 patients during this period undergo orthotopic heart transplantation (HT). The endovascular revascularization leads to LV volumes reduction, increase of ejection fraction and decrease of pulmonary artery pressure. Progress CHF is followed by negative dynamics of these characteristics and need of HT performance. In 74% of cases the effect of myocardial revascularization allows to provide increase in life expectancy of potential recipients of heart with the chronic ischemic heart failure.  

Conclusion. Performance of PCI at patients with the chronic ischemic heart failure can delay heart transplantation or become its alternative.

1. http://ossn.ru/upload/medialibrary/003/РекомендацииОССН_МЗ_30012017.pdf – дата обращения 12 февраля 2018 года.

2. Felker GM. A standardized defi nition of ischemic cardiomyopathy for use in clinical research / G.M. Felker, L.K Shaw, C.M O’Connor. Journal of the American College of Cardiology. 2002; 39 (2): 210–218.

3. Gardner RS, McDonagh TA. Chronic heart failure: epidemiology, investigation and management. Medicine. 2014; 42 (10): 562–567.

4. http://transpl.ru/images/cms/data/pdf/nacionalnye_klinicheskie_rekomendacii_po_transplantacii_serdca.pdf – дата обращения 12 февраля 2018 года.

5. Bagnenko SF. Analiz prichin defi cita donorov organov i osnovnye napravleniya ego preodoleniya / S.F. Bagnenko, Yu.S. Polushin, Ya.G. Mojsyuk. Transplantologiya. 2011; 2–3: 10–22.

6. Cleland JG, Calvert M, Freemantle N et al. The heart failure revascularisation trial (HEART). Eur. J. Heart. Fail. 2011; 13: 227–233.

7. Mironkov AB, Chestuhin VV, Blyahman FA, Shklyar TF, Ostroumov EN, Sahovskij SA, Mironkov BL. Ocenka potenciala miokarda k povysheniyu funkcional’nogo rezerva v rezul’tate revaskulyarizacii u pacientov s hronicheskoj serdechnoj nedostatochnost’yu ishemicheskogo geneza. Evrazijskij kardiologicheskij zhurnal. 2016; 3: 126–127.

8. Mironkov AB, Sahovskij SA, Ostroumov EN, Chestuhin VV, Mironkov BL. Otdalennye rezul’taty vypolneniya koronarnoj angioplastiki u pacientov s ishemicheskoj bolezn’yu serdca, oslozhnennoj zastojnoj serdechnoj nedostatochnost’yu. Byulleten’ Nauchnogo centra serdechnososudistoj hirurgii im. A.N. Bakuleva RAMN. Serdechno-sosudistye zabolevaniya. 2016; 17 (6): 262.

9. Mironkov AB, Gendlin GE, Reznik EV, Nikitin IG, Sahovskij SA, Mironkov BL, Gautier SV. Rezul’taty revaskulyarizacii miokarda bol’nyh s tyazheloj HSN ishemicheskoj ehtiologii. Serdechnaya nedostatochnost’. 2017; 3: 163–171.

10. Mironkov AB, Chestuhin VV, Blyahman FA, Shklyar TF, Ostroumov EN, Sahovskij SA, Mironkov BL. Prognozirovanie klinicheskogo effekta revaskulyarizacii miokarda u pacientov s hronicheskoj serdechnoj nedostatochnost’yu ishemicheskogo geneza. Diagnosticheskaya i intervencionnaya radiologiya. 2017; 11 (1): 46–54.